Latigo Biotherapeutics, Inc. LTGO
13.89 USD +0.56 (+4.17%)
Nov 11, 2026, 2:58 PM EST
13.36 Day range 14.35
10.24 52-week range 25.93
- YTD
- -23.91%
- 1 year
- -23.91%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| -110.39M | -63.45M | |
| -109.17M | -61.18M | |
| -129.23 | -90.10 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| 69.63M | 17.92M | |
| 75.52M | 22.86M | |
| 18.61M | 14.93M | |
| 690.00K | 851.00K | |
| -231.67M | -129.60M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| -97.56M | -50.95M | |
| -136.00K | -72.00K | |
| 149.50M | 607.00K | |
| -136.00K | -72.00K | |
| 51.80M | -50.42M |